We found that at the pre-symptomatic stage the A2AR-mediated presynaptic facilitatory action on neuromuscular transmission is exacerbated, whereas in the early symptomatic phase, this excitatory action disappears, indicating that indeed that A2AR function changes upon ALS progression. This evidence concerns the gene ADORA2A and amyotrophic lateral sclerosis.